Biocat is the organization that champions the healthcare and life sciences ecosystem in Catalonia working to transform science and technology into regional economic growth as well as social impact. Biocat focuses its strategy on different key points: • Raising awareness and promoting the ecosystem, creating tools and strategies for improving the knowledge of the Catalan healthcare sector and increasing its projection both at home and abroad, with the aim of positioning the BioRegion as an international reference. • Providing innovative training and developing talent, by designing and executing programs and initiatives to improve talent and entrepreneurship considered essential factors for the growth of the sector. • Accelerating technology transfer and business growth by supporting and carrying out activities for increasing the value of the sector, placing special emphasis on the added value of research, knowledge and technology transfer, internationalization and access to capital. Areas of specialization: Entrepreneurship, training and talent, internationalization, scientific debate, strategic projects.

Celon Pharma Inc. is an integrated biopharmaceutical company dedicated to the research, development, production, and sales and marketing of pharmaceutical products. The company has its own R&D laboratories consisting of Organic Synthesis Laboratory, Laboratory Methods of Pharmaceutical Control Laboratory and Quality Assurance and Research and Development Laboratory of Biotechnology Medicines, allowing it to develop their own innovative pharmaceutical technologies utilization of available laboratory facilities and hardware, as well as experience staff involved scientists. Celon Pharma Department of Research and Development for Innovative Medicines include: Laboratory of Medical Chemistry, Oligonucleotide Synthesis, Molecular Biology and Cell Culture Laboratory, as well as unique in the country's private NMR Laboratory. The Company has the necessary facilities to carry out research into innovative medicines. We are very acitve in validating the therapeutic suitability of chemical molecules using biochemical, physiological and molecular biology methods. The company has a modern manufacturing facility, which produces dry pharmaceutical forms. In recent years, the company has launched products in the following therapeutic areas: oncology (medicine Aromek ® - breast cancer), diseases of the nervous system: (a drug Donepex ® - Alzheimer's disease, drugs: Ketrel ®, Olasyn ® and Candela ® - schizophrenia) heart disease (drugs Valzek ®, Grepid ®, Cilapril ®) and HIV treatment (drug Lazivir ®). Celon Pharma as part of an innovative research and development activities currently employs 60 professionals with training in the field of medicinal chemistry, biology, biotechnology and pharmaceuticals.

Essilor is the world leader for corrective lenses, From design to manufacture, to correct and protect eyesight. Its mission is to "improve lives by improving sight". The group is present in more than 100 countries, strategy is driven by innovation.

GE Healthcare, as a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world.

GLINTT has become a major contributor for innovation in assisted living technologies and intelligent systems in healthcare, with a major projection in Portugal and Spain but increasingly worldwide. In fact, Glintt, or Global Intelligent Technologies, is a multi-national technology services, consulting and outsourcing group. It is one of the biggest Portuguese IT companies, listed in the NYSE Euronext Lisbon, under the symbol GLINTT. As of 2015, the company reported revenues of €69,5 M, with over 900 employees, directly operating in Portugal, Spain, Angola and Brazil and serving additional clients across more than eight countries.

IESE Business School is dedicated to training professional managers, with international educational programmes, including those with a particular focus on innovation management in the Health sector. IESE Centre for Research in Healthcare Innovation Management (CRHIM), created in 2012, builds on over 30 years of expertise in the sector. It enables public and private R&I projects to become a reference centre for health innovation management. Specialist areas include: Health management, health economics, business development, executive education, capacity-building activities.

The Instituto Pedro Nunes (IPN) is a non-profit private organization, which promotes innovation and the transfer of technology, establishing the interface between the scientific and technological environment and the production sector. Created in 1991 through an initiative of the University of Coimbra, IPN has currently a team of almost 100 permanent staff to support start-ups and researchers in these activities. With a self-sustained business model that gives the flexibility and capacity to accompany business sector needs, IPN operates in three complementary areas: Highly specialized training, Research and technological development, and Incubation and acceleration of technology-based enterprises. In terms of applied research and technological development, IPN’s technological infrastructure includes a set of six laboratories in diversified technological areas which, along with its established connections with higher education institutions, R&TD organizations and both national and international companies, place IPN in a privileged position for jointly conducting R&TD activities with enterprises. As for the incubation and acceleration of technology-based enterprises, IPN assists start-ups with technical guidance in the establishment and early stages of business development, tutorial follow-up for developing business plans, support for attracting investment and securing funding, intellectual property and legal assistance (e.g. technology transfer contracts and the registration of patents or brands), access to and contact with various national and international research centres, knowledge institutions and sources of funding.

KTH is Sweden's largest technical university with education and research spanning from natural sciences to all branches of engineering, including life science, mathematical and computational sciences, infrastructure in health, and medical devices.

KU Leuven (together with University Hospitals Leuven) is a research-intensive, internationally oriented university that carries out excellence-driven research in health and care and is dedicated to build bridges between science, society and industry.

The mission of the LUMC is ‘to be an innovator improving both healthcare and population health’. LUMC is a university medical center for research, education and patient care with a high quality profile and a strong scientific orientation. It has a unique research practice, ranging from pure fundamental medical research to applied clinical research. LUMC wants to perform ground-breaking innovation. Researchers, educators and healthcare providers at LUMC work together around 3 societal outreach topics, Oncology, Regenerative Medicine and Population Health. Furthermore 10 themes for innovation are defined Academic Pharma, Neuro Science, Cancer, (auto)Immunity, Cell, Tissue & organ, Cardio-Vascular, Genetics, infection, Life course and prevention and Lifestyle. https://strategie.lumc.nl/en/

MUL is among the largest state-owned medical Universities in Poland. It has reached a leading position in the following research areas: immunology, molecular biology, genetics of homeostasis disorders, oncology, hypertension and endocrinology. Within the last two years, young researchers from MUL were considered leaders in areas such as cardiology, oncology, immunology and dermatology.

Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: Developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and academic laboratories, clinical centres and educational establishments, promoting transfer of innovative technologies; strengthening international competitiveness for the French “health and leading-edge health technology” sector promoting those involved and stimulating the Paris Region’s capacity for innovation; Helping to increase the attractiveness of the Paris Region and the vitality of its healthcare sector

BioInnovate Ireland is a forum which combines resources to catalyse and lead medical innovation. Its training programme aims to act as a neutral territory where academia, clinicians and industry can collaborate on developing novel medical technologies. The programme is an active partnership between multiple universities (NUI Galway, University of Limerick and University College Cork). It engages with hospitals all over the country, and is supported by Enterprise Ireland, IMDA and multiple industry sponsors.

RISE Research Institutes of Sweden is a network of research and technology organizations. In global cooperation with academia, enterprise and society, we create value, growth and competitiveness through research excellence and innovation.

Sorbonne University is a multidisciplinary, research-intensive and world-class academic institution. Firmly rooted in the heart of Paris, it is committed to the success of its students and devoted to meeting the scientific challenges of the 21st century. Sorbonne Université is a multidisciplinary research university created on January 1st 2018 by the merging of the Universities Paris-Sorbonne and Pierre et Marie Curie. It is made of three faculties, in Sciences, Medicine and Humanities, and trains 54,000 students, among who 4,700 PhD students and 10,200 international students.

TU Delft is the largest technical university in the Netherlands and covers practically the entire spectrum of engineering sciences. An important characteristic of TU Delft is that we not only strive to be good at what we do, but also that we want to be good for something. At Delft University of Technology, we aim for a balance between pursuing world-class academic excellence, providing high quality education and developing expert solutions for societal challenges. Also key at TU Delft is the integration of research, education and innovation. Technical-scientific knowledge is a breeding ground for our education and innovation. Conversely, the interaction with students, companies and societal partners leads to new and unexpected research questions. Research, education and innovation inspire each other.
Our vision: Delft University of Technology contributes to solving global challenges by educating new generations of socially responsible engineers and expanding the frontiers of the engineering sciences.
Our misson
• We perform world-class research by combining science, engineering and design in a socially responsible manner. Thus, we advance and share the benefits of technology.
• We develop and enhance the expertise of tomorrow’s engineering leaders and educate professional, high-level and responsible engineers throughout their careers.
• We help to develop and deliver technology-driven, innovative solutions to societal problems through collaborations with leading national and international partners whilst being firmly rooted in Delft.
• We continuously improve our collective effectiveness, performance and organisational resilience through the principles and practice of professionalism, collaboration and openness.

Universidad Politécnica de Madrid health activities cover a wide variety of topics, being the Biotech initiative its flagship: a stable interdisciplinar environment grouping UPM research groups with high expertise and qualified infrastructure to address major challenges in Biomedicine and Health. With special focus in ICT for health, UPM has capabilities and R&D results in all EIT Health areas in order to transfer advanced ICT and Health solutions and technologies to the Industry partners, to validate those solutions in our Living Labs, to promote the start-up of new ventures issued by UPM community and regional Health ecosystem, and to offer high quality and experienced educational programmes.

University of Coimbra (UC) is a reference in higher education and R&D in Portugal, due to the quality of the courses taught at its eight colleges and to the advances achieved in pure and applied research in various scientific domains and on technology related areas. The offer in technological research makes UC an undeniable reference in R&D in Portugal, which highlights the excellence of work developed by the R&D units of UC, namely in the fields of life sciences. UC offers advanced entrepreneurship education trainings programs in different areas that bind to technology, where it was considered by EC as one of the 20 most inspiring cases in Europe. UC stands out also on technology transfer being involved in the promotion of several successful initiatives, like IPN Incubator, TECBis- Business accelerator unit, Biocant, and in the creation of more than 200 technological spin-offs, the majority of them healthcare related businessess. UC U-Multirank scored “very good” (the maximum classification) on Research, Technology Transfer and Internationalisation.

With over 40,000 students and more than 9,500 employees, UCPH – founded 1479 – is among the largest comprehensive universities in Europe. It is ranked No. 7 in Europe and no. 39 in the world in the Academic Ranking of World Universities 2015. The University has an international environment where ambitious researchers and students strive for new knowledge and insights. UCPH is placed at the centre of a stimulation entrepreneurial ecosystem in the Greater Copenhagen Area.

The University of Oxford is one of the leading research and teaching Universities in the United Kingdom and Europe. The Medical Sciences division has major global collaborations across the breadth of biomedical sciences.

The UGA in Grenoble is a leading University of Science Technology and Health. Within 80 multidisciplinary laboratories, the UGA is developing outstanding research at national and international level. The UGA offers a wide range of training courses, from bachelor to doctorate, in close connection with the socio-professional environment to promote the integration of its students.